Safety and immunogenicity of a vaccine against SARS-CoV-2
Posted 20 Aug 2020
Dr Julie Oliver
Dr Julie Oliver summarises a recent Lancet paper reporting results of the first clinical study of ChAdOx1 nCoV-19, a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.